Cigna Group stock rises 2.52 percent, outperforming competitors on mixed market day
Updated
Updated · MarketWatch · Apr 27
Cigna Group stock rises 2.52 percent, outperforming competitors on mixed market day
10 articles · Updated · MarketWatch · Apr 27
Cigna Group shares closed at $282.58 on Monday, with trading volume at 1.5 million, below the 50-day average.
The stock remains 19.26% below its 52-week high of $350.00, reached on May 2. Competitors UnitedHealth fell, while CVS Health and Elevance Health posted gains.
Despite the broader market showing mixed results, Cigna Group's performance outpaced most peers, reflecting investor confidence amid fluctuating market conditions.
Why do analysts claim Cigna is 70% undervalued amid escalating fines and lawsuits?
Can Cigna's acquisitions offset its shrinking customer base and industry pressures?
Is Cigna's stock a deep value buy or a trap set by its controversial AI practices?
With a new CEO incoming, will Cigna's focus shift from profits to patients?
Will Cigna’s new rebate-free model truly lower drug costs for consumers?